{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:42:21Z","timestamp":1775040141187,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,1]]},"DOI":"10.7759\/cureus.106251","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T08:40:46Z","timestamp":1775032846000},"source":"Crossref","is-referenced-by-count":0,"title":["Shiga Toxin-Producing Escherichia coli-Associated Hemolytic Uremic Syndrome Following Neoadjuvant Chemotherapy for Advanced Ovarian Cancer: A Case Report"],"prefix":"10.7759","author":[{"given":"Ratko","family":"Deli\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01202-8","article-title":"Haemolytic uraemic syndrome","volume":"400","author":"Michael M","year":"2022","unstructured":"Michael M, Bagga A, Sartain SE, Smith RJ. Haemolytic uraemic syndrome. Lancet. 2022, 400:1722-40. 10.1016\/S0140-6736(22)01202-8","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-11-709865","article-title":"HUS and atypical HUS","volume":"129","author":"Jokiranta TS","year":"2017","unstructured":"Jokiranta TS. HUS and atypical HUS. Blood. 2017, 129:2847-56. 10.1182\/blood-2016-11-709865","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3289","article-title":"A case of typical hemolytic uremic syndrome in an adult","volume":"10","author":"Kouzy R","year":"2018","unstructured":"Kouzy R, Alawieh R, Sukhon F, Temraz S. A case of typical hemolytic uremic syndrome in an adult. Cureus. 2018, 10:e3289. 10.7759\/cureus.3289","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2016.012096","article-title":"Microangiopathic hemolytic anemia and thrombocytopenia in patients with cancer","volume":"12","author":"Morton JM","year":"2016","unstructured":"Morton JM, George JN. Microangiopathic hemolytic anemia and thrombocytopenia in patients with cancer. J Oncol Pract. 2016, 12:523-30. 10.1200\/JOP.2016.012096","journal-title":"J Oncol Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3201\/eid2707.204638","article-title":"Shiga toxin-associated hemolytic uremic syndrome in adults, France, 2009-2017","volume":"27","author":"Travert B","year":"2021","unstructured":"Travert B, Dossier A, Jamme M, et al.. Shiga toxin-associated hemolytic uremic syndrome in adults, France, 2009-2017. Emerg Infect Dis. 2021, 27:1876-85. 10.3201\/eid2707.204638","journal-title":"Emerg Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/toxins15010010","article-title":"Diagnosis and treatment for Shiga toxin-producing Escherichia coli associated hemolytic uremic syndrome","volume":"15","author":"Liu Y","year":"2022","unstructured":"Liu Y, Thaker H, Wang C, Xu Z, Dong M. Diagnosis and treatment for Shiga toxin-producing Escherichia coli associated hemolytic uremic syndrome. Toxins (Basel). 2022, 15:10010. 10.3390\/toxins15010010","journal-title":"Toxins (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1089\/fpd.2010.0673","article-title":"Escherichia coli O157:H7: animal reservoir and sources of human infection","volume":"8","author":"Ferens WA","year":"2011","unstructured":"Ferens WA, Hovde CJ. Escherichia coli O157:H7: animal reservoir and sources of human infection. Foodborne Pathog Dis. 2011, 8:465-87. 10.1089\/fpd.2010.0673","journal-title":"Foodborne Pathog Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-018-4105-1","article-title":"Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS)","volume":"34","author":"Khalid M","year":"2019","unstructured":"Khalid M, Andreoli S. Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS). Pediatr Nephrol. 2019, 34:2495-507. 10.1007\/s00467-018-4105-1","journal-title":"Pediatr Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2012.196","article-title":"Renal and neurological involvement in typical Shiga toxin-associated HUS","volume":"8","author":"Trachtman H","year":"2012","unstructured":"Trachtman H, Austin C, Lewinski M, Stahl RA. Renal and neurological involvement in typical Shiga toxin-associated HUS. Nat Rev Nephrol. 2012, 8:658-69. 10.1038\/nrneph.2012.196","journal-title":"Nat Rev Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12020067","article-title":"Shiga toxin-associated hemolytic uremic syndrome: a narrative review","volume":"12","author":"Joseph A","year":"2020","unstructured":"Joseph A, Cointe A, Mariani Kurkdjian P, Rafat C, Hertig A. Shiga toxin-associated hemolytic uremic syndrome: a narrative review. Toxins (Basel). 2020, 12:20067. 10.3390\/toxins12020067","journal-title":"Toxins (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0000000000000061","article-title":"Chemotherapy-associated thrombotic microangiopathy","volume":"4","author":"Aklilu AM","year":"2023","unstructured":"Aklilu AM, Shirali AC. Chemotherapy-associated thrombotic microangiopathy. Kidney360. 2023, 4:409-22. 10.34067\/KID.0000000000000061","journal-title":"Kidney360"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00212","article-title":"An update in drug-induced thrombotic microangiopathy","volume":"7","author":"Chatzikonstantinou T","year":"2020","unstructured":"Chatzikonstantinou T, Gavriilaki M, Anagnostopoulos A, Gavriilaki E. An update in drug-induced thrombotic microangiopathy. Front Med (Lausanne). 2020, 7:212. 10.3389\/fmed.2020.00212","journal-title":"Front Med (Lausanne)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-017-0727-y","article-title":"Differential diagnosis of thrombotic microangiopathy in nephrology","volume":"18","author":"Sakari Jokiranta T","year":"2017","unstructured":"Sakari Jokiranta T, Viklicky O, Al Shorafa S, et al.. Differential diagnosis of thrombotic microangiopathy in nephrology. BMC Nephrol. 2017, 18:324. 10.1186\/s12882-017-0727-y","journal-title":"BMC Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/478171-shiga-toxin-producing-escherichia-coli-associated-hemolytic-uremic-syndrome-following-neoadjuvant-chemotherapy-for-advanced-ovarian-cancer-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T08:40:54Z","timestamp":1775032854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/478171-shiga-toxin-producing-escherichia-coli-associated-hemolytic-uremic-syndrome-following-neoadjuvant-chemotherapy-for-advanced-ovarian-cancer-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.106251","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}